Peter Vandenberghe

机构：KU Leuven · ORCID：0000-0003-4719-1935

发表论文 640 篇 · 总被引 25951 次 · h-index 78

代表论文

• Cell type signatures in cell-free DNA fragmentation profiles reveal disease biology (2024 · Nature Communications · 被引 72)
• Efficacy and safety of CAR T‐cell therapy in patients with primary or secondary CNS lymphoma: A study on behalf of the EBMT and the GoCART coalition (2025 · HemaSphere · 被引 13)
• The landscape of immune monitoring in CAR-T cell therapy: A comprehensive review and survey study by the Cellular Therapy and Immunobiology Working Party of the EBMT (2025 · Blood Reviews · 被引 9)
• The impact of the bedside check of medication appropriateness (BED-CMA) at the hematology ward: a mixed-methods study (2025 · International Journal of Clinical Pharmacy · 被引 3)
• DAGIP: alleviating cell-free DNA sequencing biases with optimal transport (2025 · Genome biology · 被引 3)
• Functional MRGPRX2 expression on peripheral blood-derived human mast cells increases at low seeding density and is suppressed by interleukin-9 and fetal bovine serum (2024 · Frontiers in Immunology · 被引 3)